Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jan 22;4(4):e1001204. doi: 10.1080/2162402X.2014.1001204

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Author(s). Published with license by Taylor & Francis Group, LLC

© Fusanori Yotsumoto, Weon-Kyoo You, Pilar Cejudo-Martin, Karolina Kucharova, Kenji Sakimura, and William B Stallcup

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.

PMC Copyright notice

Figure 1. — Decreased brain tumor progression in myeloid- and pericyte-specific NG2 null mice. B16F10 tumors in control versus Mac-NG2ko mice (A) and in control vs. PC-NG2ko mice (C) at 10 d after tumor initiation. Graphs quantify tumor volumes in control versus Mac-NG2ko mice (B) and in control vs. PC-NG2ko mice (D). Data in B represent 21 control and 20 Mac-NG2ko mice. Data in D represent 22 control and 18 PC-NG2ko mice. *p < 0.01 compared to controls. (E, F). Kaplan–Meier survival curves for control (n = 7) versus Mac-NG2ko (n = 10) and control (n = 14) vs. PC-NG2ko (n = 12) mice (p < 0.5). (G, H). Terminal tumor volumes for control versus Mac-NG2ko mice and for control vs. PC-NG2ko mice. Each data point represents one mouse. Horizontal lines indicate mean tumor volumes.